tradingkey.logo

BUZZ-Atai Life Sciences tumbles on planned stock sale

ReutersFeb 12, 2025 9:49 PM

U.S.-listed shares of Atai Life Sciences ATAI.O down 22% to $1.99 in extended trading on stock sale news

German-based depression drug developer commences $55 mln stock offering

Co intends to use net offering proceeds for general purposes, including to advance clinical development of product candidates and programs

Berenberg sole bookrunner

Co has 167.8 mln shares outstanding, giving it a ~$428 mln market cap

ATAI shares finished up 14.3% at $2.55 on Weds. Stock ended 2024 at $1.33

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI